To test whether the scFv‐l‐DNA complex can be absorbed into animal bloodstream and distributed to the tumor sites via the circulatory system, we examined its antitumor activity in mice in a subcutaneous CD19+ Raji xenograft model. The gene discussed is CD19; the disease is neoplasm.